{
  "trial_id": "NCT01375608",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "34 years old"
    },
    {
      "criterion": "Written, informed consent provided by the subject before study entry.",
      "label": "met",
      "evidence": "The patient had severe pain in his lower back that radiated to both thighs scored 9 out of 10."
    },
    {
      "criterion": "Confirmed SCD (SS, S-beta (0)-thalassemia, or SC on hemoglobin electrophoresis)",
      "label": "met",
      "evidence": "Hemoglobine electrophoresis: 91% HbS 6%HbF 3%HbA2"
    },
    {
      "criterion": "Symptomatic SCD while on 6 months of HU OR symptomatic SCD and intolerant of HU",
      "label": "met",
      "evidence": "The patient had severe pain in his lower back that radiated to both thighs scored 9 out of 10."
    },
    {
      "criterion": "Symptomatic SCD is defined as having one of following:",
      "label": "met",
      "evidence": "HbF <5 percent, OR 3 or more pain episodes per year requiring parenteral narcotics, OR 1 or more acute chest syndrome episodes, OR Hemoglobin <9 degree g/dL and ARC less than or equal to 250,000/mm(3)"
    },
    {
      "criterion": "Subject is in his/her steady state and not amidst any acute complication due to SCD.",
      "label": "met",
      "evidence": "The patient is afebrile within the normal blood pressure. No splenomegaly was detected in the physical exam."
    },
    {
      "criterion": "Willing to use 2 forms of contraception.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Inability to give informed consent.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Experienced severe sepsis or septic shock within the previous 12 weeks.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Last HU or erythropoietin dose obtained within the previous 4 weeks.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Participant is on chronic transfusion therapy (e.g., for history of TIA or stroke) and medically contraindicated to discontinue transfusions.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Currently pregnant or breast-feeding.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Sexually active female of childbearing potential (all females except those who are menopausal [appropriate age and no period for more than 12 months] or have had a hysterectomy and/or bilateral oophorectomy) who is unwilling to use at least 2 acceptable methods of contraception as determined by the investigators.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Sexually active male whose partner is of child-bearing potential and who is unwilling to use at least 2 acceptable methods of contraception as determined by the investigators during treatment and for 8 weeks after the last dose of decitabine.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Moribund or any concurrent disease (e.g., hepatic, renal, cardiac, metabolic) of such severity that death within 24 weeks is likely.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "The patient has had positive history of sickle cell crises since childhood. He also had the same symptoms in past two weeks treated with oxycodone which was not beneficial to his pain.",
  "_meta": {
    "topic_id": "45",
    "trial_id": "NCT01375608",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}